PANews reported on September twenty second, in accordance with 21CBR , that Huajian Medical introduced the completion of the Nanjing ETHK Constructing, positioning itself because the world’s first devoted R&D base for digital real-world belongings ( RWAs ). Since July , Huajian Medical has acquired a controlling stake in Guofu Quantum and established an modern drug mental property tokenization fund, growing its market capitalization from HK$ 3 billion to HK$ 17 billion. The corporate has been renamed “Huajian Digital Trade Group” and is collaborating with Renhe Pharmaceutical to ascertain an OTC drug RWA alternate in the USA, selling the digitization and on-chain circulation of medical belongings.
